Literature DB >> 18835343

Particulate drug interactions with polymeric and elastomeric valve components in suspension formulations for metered dose inhalers.

Jeff James1, Martyn Davies, Richard Toon, Phil Jinks, Clive J Roberts.   

Abstract

PURPOSE: To characterise the adhesive interactions between three pulmonary active pharmaceutical ingredient (API) materials and the components of pressurised metered dose inhalers (pMDIs) obtained from two commercially available products (termed 'Prod-1' and 'Prod-2'). This is of potential interest, as a greater understanding of the interactions between specific APIs and surfaces may aid manufacturers in component selection during pMDI system development.
METHODS: The theoretical work of adhesion (DeltaG(132)) for each API-pMDI component interaction was calculated using the surface component analysis (SCA) approach. These results were correlated with corresponding API-pMDI component separation energy measurements determined using colloid probe AFM.
RESULTS: Strong correlations existed between separation energy and the DeltaG(132) parameters where the polar contribution was accounted for. This highlighted the adhesive influence of polar surface energy on each interaction in this study. Generally the largest adhesive interactions involved APIs and pMDI components which have a bipolar surface energy (i.e. both gamma(-) and gamma(+) >1 mJ m(-2)).
CONCLUSIONS: For each API-pMDI interaction in this study, the polar component of surface energy has the greater influence on adhesive events. The bipolar surface energetics of certain APIs and pMDI components were deemed responsible for the increased adhesive interactions observed with these materials. This study highlights that different materials can have different effects on the adhesive interactions with particulate APIs; information that could aid the manufacturer in producing more effective and efficient pMDI systems.

Mesh:

Substances:

Year:  2008        PMID: 18835343     DOI: 10.1016/j.ijpharm.2008.09.018

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Advances in metered dose inhaler technology: formulation development.

Authors:  Paul B Myrdal; Poonam Sheth; Stephen W Stein
Journal:  AAPS PharmSciTech       Date:  2014-01-23       Impact factor: 3.246

2.  Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).

Authors:  Martin Rowland; Alessandro Cavecchi; Frank Thielmann; Janusz Kulon; Jag Shur; Robert Price
Journal:  Pharm Res       Date:  2018-11-26       Impact factor: 4.200

3.  Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).

Authors:  Elizabeth Cocks; Satyanarayana Somavarapu; Oya Alpar; David Greenleaf
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.